Baker Bros. Advisors’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $4.4M | Hold |
|
|||||
|
2024
Q1 | $4.45M | Hold |
|
|||||
|
2023
Q4 | $3.79M | Hold |
|
|||||
|
2023
Q3 | $2.93M | Buy |
|
|||||
|
2023
Q2 | $3.66M | Hold |
|
|||||
|
2023
Q1 | $3.74M | Hold |
|
|||||
|
2022
Q4 | $3.4M | Hold |
|
|||||
|
2022
Q3 | $5.2M | Hold |
|
|||||
|
2022
Q2 | $6.19M | Hold |
|
|||||
|
2022
Q1 | $10.8M | Hold |
|
|||||
|
2021
Q4 | $30.6M | Buy |
|
|||||
|
2021
Q3 | $47.3M | Hold |
|
|||||
|
2021
Q2 | $83.5M | Hold |
|
|||||
|
2021
Q1 | $97.3M | Buy |
|